All Articles

Overview of clinical trial results for stem cell therapy in orthopedic injuries: efficacy, safety, delivery methods, sources, and regulatory challenges.

Clear overview of cord blood, cord tissue, placenta, and amniotic fluid stem cells — collection, storage, medical uses, and ongoing clinical research.

Practical ways to offset private cord blood banking costs — HSAs/FSAs, insurance, employer reimbursements, tax deductions, and flexible payment plans.

A clear comparison of AABB and FACT cord blood accreditation — scope, update cycles, clinical vs. technical focus, shared safety requirements, and verification tips.

Cord blood offers faster access and lower chronic GVHD but slower engraftment and higher early infection risk than bone marrow.

Umbilical cord hUC-MSCs can regenerate cartilage, lower inflammation, and improve joint function for osteoarthritis with low immune risk and clinical evidence.

Explains multi-layer protections for cord blood: nitrogen cryostorage at −196°C, UPS/generator backups, 24/7 monitoring, GenVault disaster recovery, and data redundancy.

Bank newborn cord blood and tissue to preserve stem cells that can treat 80+ conditions, shorten donor searches, and provide faster access to therapy.

Overview of stem cell approaches for MS—HSCT, MSCs, perinatal cells, and exosomes—clinical trial outcomes, safety and newborn stem cell banking options.